Behrooz Sadeghi Kalani

Dr. Behrooz Sadeghi Kalani

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2023 in Briefings in Bioinformatics
Verified
Journal Article
Open access
PDF file
MAMaryam Asadinezhad
Maryam Asadinezhad
SKSaeed Khoshnood
Saeed Khoshnood
PAParisa Asadollahi
Parisa Asadollahi
SGSobhan Ghafurian
Sobhan Ghafurian
NSNourkhoda Sadeghifard
Nourkhoda Sadeghifard
BKBehrooz Sadeghi Kalani
Behrooz Sadeghi Kalani
The rising issue of antibiotic resistance has made treating Pseudomonas aeruginosa infections increasingly challenging. Therefore, vaccines have emerged as a viable alternative to antibiotics for preventing P. aeruginosa infections in susceptible individuals. With its superior accuracy, high efficiency in stimulating cellular and humoral immune responses, and low cost, mRNA vaccine technology is quickly replacing traditional methods. This study aimed to design a novel mRNA vaccine by using in silico approaches against P. aeruginosa. The research team identified five surface and antigenic proteins and selected their appropriate epitopes with immunoinformatic tools. These epitopes were then examined for toxicity, allergenicity and homology. The researchers also checked their presentation and identification by major histocompatibility complex cells and other immune cells through valuable tools like molecular docking. They subsequently modeled a multi-epitope protein and optimized it. The mRNA was analyzed in terms of structure and stability, after which the immune system’s response against the new vaccine was simulated. The results indicated that the designed mRNA construct could be an effective and promising vaccine that requires laboratory and clinical trials.

1 December 2020 in Gene Reports
Verified
Journal Article
Closed access
NNNegar Narimisa
Negar Narimisa
FAFatemeh Amraei
Fatemeh Amraei
BKBehrooz Sadeghi Kalani
Behrooz Sadeghi Kalani
AAAsaad Azarnezhad
Asaad Azarnezhad
FJFaramarz Masjedian Jazi
Faramarz Masjedian Jazi

14 June 2019 in Acta Microbiologica Et Immunologica Hungarica
Verified
Journal Article
Closed access
Ali ShivaeeAli Shivaee
Ali Shivaee
RMRokhsareh Mohammadzadeh
Rokhsareh Mohammadzadeh
SSShahla Shahbazi
Shahla Shahbazi
EPElahe Pardakhtchi
Elahe Pardakhtchi
EOElnaz Ohadi
Elnaz Ohadi
BKBehrooz Sadeghi Kalani
Behrooz Sadeghi Kalani
Staphylococcus epidermidis is an opportunistic pathogen causing infections related to the usage of implants and medical devices. Pathogenicity of this microorganism is mainly linked to its capability to form biofilm structures. Biofilm formation vastly depends on several factors including different proteins. We studied the expression levels of three proteins including SdrH, Bap, AtlE, and MazF at different time intervals during the course of biofilm formation. In this study, a catheter-derived S. epidermidis isolate with strong ability of biofilm formation was selected. PCR assay was used to detect sdrH, bap, atlE, and mazF genes in this isolate. Real-time PCR was used to determine the expression levels of these genes after 4, 8, and 20 h during the course of biofilm formation. The studied genes showed different expression levels at different time intervals during biofilm formation by real-time PCR method. Expression levels of atlE and sdrH genes were the highest at 4 h, whereas bap gene showed the highest expression level at 8 h during the course of biofilm formation. In addition, the expression level of mazF gene peaked at 4 h and then progressively decreased at 8 and 20 h. Our results suggest the importance of AtlE, SdrH, and MazF proteins in the establishment and development of the biofilm structure. In addition, our results showed the important role of protein Bap in the accumulation of biofilm structure. Future studies are required to understand the exact role of MazF in the process of biofilm formation.

15 May 2019 in International Journal of Peptide Research and Therapeutics
Verified
Journal Article
Closed access
PDF file
RMRokhsareh Mohammadzadeh
Rokhsareh Mohammadzadeh
Ali ShivaeeAli Shivaee
Ali Shivaee
EOElnaz Ohadi
Elnaz Ohadi
BKBehrooz Sadeghi Kalani
Behrooz Sadeghi Kalani

10 January 2022 in International Journal of Peptide Research and Therapeutics
Verified
Journal Article
Closed access
PDF file
PAParisa Asadollahi
Parisa Asadollahi
IPIraj Pakzad
Iraj Pakzad
NSNourkhoda Sadeghifard
Nourkhoda Sadeghifard
SGSobhan Ghafourian
Sobhan Ghafourian
HKHossein Kazemian
Hossein Kazemian
BKBehrooz Sadeghi Kalani
Behrooz Sadeghi Kalani

25 October 2023 in Gut Pathogens
Verified
Journal Article
Open access
PDF file
Ali ShivaeeAli Shivaee
Ali Shivaee
SBSara Bahonar
Sara Bahonar
MGMehdi Goudarzi
Mehdi Goudarzi
AHAli Hematian
Ali Hematian
BHBahareh Hajikhani
Bahareh Hajikhani
BKBehrooz Sadeghi Kalani
Behrooz Sadeghi Kalani
Aims: L.monocytogenes monocytogenes is an omnipresent bacterium that causes a fatal food-borne illness, listeriosis. The connection of this bacterium to E-cadherin through internalin A plays a significant role in the internalization of the bacteria. In this study, this interaction has been investigated for the design of an inhibitory peptide. Methods: The interaction of the proteins involved in the entry of bacteria was evaluated by molecular docking. According to their interactions, an inhibitory peptide was designed to bind to internalin A by server peptiderive. Its effects on L.monocytogenes invasion on the Caco-2 cell line and biofilm formation were also assessed. Findings: Docking results showed that the peptide has a high affinity for binding to Internalin A. The synthesized peptide at a concentration of 64 µg/ml inhibited 80% of the invasion of L.monocytogenes into the Caco-2 cell line. Furthermore, the studied peptide at the highest concentration had a slight inhibitory effect on biofilm formation. Conclusion: These results reveal that short polypeptides can impede the invasion of target cells by L. monocytogenes in vitro and could be advantageous as restoring agents in vivo.